IDAMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Idamycin patents expire, and when can generic versions of Idamycin launch?
Idamycin is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in IDAMYCIN is idarubicin hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Idamycin
A generic version of IDAMYCIN was approved as idarubicin hydrochloride by MEITHEAL on May 1st, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IDAMYCIN?
- What are the global sales for IDAMYCIN?
- What is Average Wholesale Price for IDAMYCIN?
Summary for IDAMYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 66 |
| Clinical Trials: | 31 |
| Patent Applications: | 6,623 |
| Drug Prices: | Drug price information for IDAMYCIN |
| DailyMed Link: | IDAMYCIN at DailyMed |
Recent Clinical Trials for IDAMYCIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| First Affiliated Hospital of Shantou University Medical College | Phase 2/Phase 3 |
| Third Affiliated Hospital, Sun Yat-Sen University | Phase 2/Phase 3 |
| Southern Medical University, China | Phase 2/Phase 3 |
US Patents and Regulatory Information for IDAMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | IDAMYCIN | idarubicin hydrochloride | INJECTABLE;INJECTION | 050661-002 | Sep 27, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | IDAMYCIN PFS | idarubicin hydrochloride | INJECTABLE;INJECTION | 050734-001 | Feb 17, 1997 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | IDAMYCIN | idarubicin hydrochloride | INJECTABLE;INJECTION | 050661-001 | Sep 27, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | IDAMYCIN | idarubicin hydrochloride | INJECTABLE;INJECTION | 050661-003 | Apr 25, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
